Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bavisant for alcohol craving
NCT01362699Phase 2Withdrawn
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol dependence comparing JNJ-31001074 with Placebo (2 arms). Primary endpoint: Urge to drink alcohol at 1 week. Planned start Aug 2011; status: withdrawn.
02
Drugs
bavisant
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT01362699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362699.